Urology in the News - May 27, 2013 Robot fails to impress in bladder cancer surgeryHigh-tech approach no better than conventional open procedure New U.S. guideline nixes prostate cancer screening in under-55s Two-year interval suggested for older men who opt for testing Prostate cancer: More men can opt for active surveillance Not all conventional criteria need to be fulfilled, analysis shows Intermittent versus continuous prostate cancer therapy: New trial raises cautions in metastatic disease Researchers unable to conclude the two strategies produce equivalent results Made-in-Canada technology aims to zap early prostate cancer Safety trial of MRI-guided ultrasound ablation launched in Ontario Contrast-free urograms possible in minor hematuria cases Study shows no impact on detection of clinically significant findings Myrbetriq: first beta-3 agonist for overactive bladder coming soon Medication is the first in a new class of drugs used to manage overactive bladder. Patients on androgen-deprivation therapy receive inadequate bone health care Most lack basic information about bone health, are not receiving appropriate screening, and are not engaging in appropriate healthy bone behaviours, study finds. Beware the shrinking penis Researchers raise awareness of a little-known side-effect of prostate cancer therapy First Previous 10 11 12 13 14 Next Last
